Psychological adjustment in patients with an implantable cardioverter defibrillator: primary prevention and secondary prevention. A comparative study
e202005038
Keywords:
Psychological adjustment, Implantable cardioverter defibrillator, Primary prevention, Secondary preventionAbstract
Background: The implantation of the Implantable Cardioverter Defibrillator (ICD) influences the psychological adjustment and the degree of subjective discomfort. The objective of this work was to analyze differences in psychological adjustment, fear of shocks and the degree of subjective discomfort derived from the illness depending on the reasons for implantation (primary vs secondary).
Methods: A sample of 82 patients with an ICD, for primary (58.5%) or secondary (41.5%) prevention indications was studied. A sociodemographic and clinical questionnaire and List of Brief Symptoms (LBS-50) was used. Descriptive univariate and bivariate analysis, t-tests on mean differences for independent samples and z-tests on proportion differences were performed.
Results: Regarding psychological adjustment, 43.9% of the patients reported to have sleeping disorder, regardless the type of prevention. A greater percentage of patients of primary prevention had scored higher in clinical scales. The 29.4% of patients with secondary prevention reported to be afraid of experiencing some shock. The 25% of patients whose type of prevention was primary showed severe or moderate level of subjective discomfort derived from the illness compared with the 14.7% of the secondary prevention patients (p=0.7).
Conclusions: The patients with an ICD show symptoms clinically significant in Psychoactivity, Obsession-Compulsion, Anxiety, Somatization, Sleeping disorders and Psychopathology Risk Index. Both groups, regardless the type of prevention showed a similar psychological adjustment. Regarding the fear of shocks and the degree of subjective discomfort derived from the illness, no statistically significant differences between the groups were found.
Downloads
References
Zipes DP, Wellens HJ. Sudden cardiac death. Circulation. 1998; 98(21):2334-51. Review.
Eisenberg MS. Resuscitate: how your community can improve survival from sudden cardiac arrest. 2nd ed. Seattle: University of Washington Press. 2013.
Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346:877–83.
Bardy GH, Lee KL, Mark DB. Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N. Engl. J Med. 2005; 352: 225–37.
Konstantino Y, Shafat T, Novack V, Novack L, Amit G. Incidence of implantable cardioverter defibrillator therapy and mortality in primary and secondary prevention of sudden cardiac death. Israel Medical Association Journal. 2015;17:760–63.
Hohnloser SH, Israel CW. Current evidence base for use of the implantable cardioverter-defibrillator. Circulation. 2013;128:172–83.
Paneque I, Carrión, MR, Fernández, JM, Pinilla P. Vivir con un desfibrilador automático implantable. Un estudio cualitativo de las experiencias de los pacientes. Index Enfermería. 2014; 23: 31-5.
Atwater BD, Daubrt JP. Implantable cardioverter defibrillators: risks accompany the life-saving benefits. Heart. 2012;98(10): 764-72.
Pedersen S, Broek K, Theuns D et al. Risk of chronic anxiety in implantable defibrillator patients: a muti-center study. International Journal of Cardiology. 2011; 147: 420-23.
Sears SF, Conto BJ. Quality of life and psychological functioning of ICD Patients. Heart. 2002;87:488–93.
Pedersen SS, Van Domburg RT, Theuns DA et al. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. American Heart Journal. 2005;149(4): 664–69.
Amaiz R, Asher E, Rozen G et al. Reduction in depressive symptoms in primary prevention ICD scheduled patients - One year prospective study. General Hospital Psychiatry. 2017;48: 37-41
Magyar-Russell G, Thombs BD, Cai JX et al. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. J. Psychosom. Res. 2011;71: 223–31.
Gostoli, S, Bonomo, M, Roncuzzi R et al. Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter desfibrillator (ICD). International Journal of Cardiology. 2016;220: 360-64.
Saskia M, Rüdiger M, Wilke S et al. Anxiety disorders in patients with implantable cardioverter defibrillators: frequency, course predictors, and patients´ request for treatment. Pace. 2014;37: 35-47.
Bilge AH, Ozben B, Demircan S et al. Depression and Anxiety Status of patients with Implantable Cardioverter Defibrillator and precipitating factors. Pace. 2006;29:619-26.
Van den Broek K, Nyklicek I, Van der Voort MD et al. Shoks, personality and anxiety in patients with an implantable defibrillator. Pace. 2008;31:850-57.
Rahmawati A, Chishaki A, Ohkusa T et al. Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator. Journal of Arrhythmia. 2016;32:102-7.
De Rivera L, Abuín M. Listado de Síntomas Breves (LSB-50). Madrid: Editorial TEA Ediciones, S.A; 2012. 79 p.
López-Torres J, Boix C, David Y et al. Functional status in the elderly with insomnia. Qual Life Res.2007;16:279-86.
López-Torres J, Navarro B, Párraga I, Andrés F, Rabanales J, Simarro MJ. El estado de salud de las personas mayores que sufren insomnio. Gaceta Sanitaria.2013;27:47-52.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Silvia Alcaraz Andreu, María Dolores Hidalgo Montesinos, Carmen Godoy Fernández, Encarna Fernández Ros, Juan José Sánchez Muñoz, Arcadio García Alberola
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
